Form 4: Blueprint Medicines Corp: Chief Scientific Officer Percy H. Carter Sells 4,000 Shares

Percy H. Carter, Chief Scientific Officer of Blueprint Medicines Corp, sold 4,000 shares of common stock on June 5, 2024, at a weighted average price of $105.13 per share.

Summary

• On June 5, 2024, Percy H. Carter, the Chief Scientific Officer of Blueprint Medicines Corp, sold 4,000 shares of the company's common stock.
• The shares were sold at a weighted average price of $105.13, with individual transactions ranging from $105.11 to $105.30 per share.
• Following the transaction, Carter directly owns 41,895 shares of Blueprint Medicines Corp.
• The sale was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an insider stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine disclosure of insider trading activity. It's common for executives to periodically sell shares for personal financial management.

Stakeholder Impact

• The sale of shares by a high-ranking officer could be perceived negatively by some investors, although it is a relatively small transaction.

Key Dates